Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age

doi:10.3748/wjg.v20.i15.4151

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 15

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7174)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

447

WORD

217

HTML

3968

Tables (1-4)

289

Sum=4921

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1035

Download

1218

Sum=2253

Apr 21, 2014 (publication date) through Jan 30, 2025

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Apr 21, 2014; 20(15): 4151-4159
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4151

Table 1 Overall survivals in sorafenib treatment

Clinical trial	Sorafenib			Placebo			P value
Clinical trial	n	Median OS (mo)	95%CI	n	Median OS (mo)	95%CI	P value
SHARP[5]	299	10.7	9.4–13.3	303	7.9	6.8–9.1	< 0.001
AP[6]	150	6.5	5.56–7.56	76	4.2	3.75–5.46	0.014

OS: Overall survival; AP: Asia-Pacific.

Citation: Miyahara K, Nouso K, Yamamoto K. Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age. World J Gastroenterol 2014; 20(15): 4151-4159
URL: https://www.wjgnet.com/1007-9327/full/v20/i15/4151.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i15.4151